Comparison

Cediranib European Partner

€38.00
Excl. VAT
Item no. TMO-T2500-2mg
Manufacturer TargetMol
CASRN 288383-20-0
Amount 2mg
Category
Type Molecules
Specific against other
Purity 0,99
Citations 1. Wedge SR, et al. Y Res. 2005 May 15; 65(10):4389-400.
Smiles Cc1cc2c([nH]1)ccc(c2F)Oc1ncnc2cc(c(cc12)OC)OCCCN1CCCC1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias AZD2171 , NSC-732208
Available
Short Description
Cediranib (AZD2171) is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro, also inhibits Flt1/4 (IC50: 5 nM/≤3 nM), similar activity against PDGFRβ and c-Kit, selective more for VEGFR than PDGFR-α (36-fold), CSF-1R (110-fold), and Flt3 (1000-fold) in HUVEC cells.
Shipping
cool pack
Storage
-20°
Target names or alias
AZD2171 , NSC-732208
Molecular Weight
450, 51
Pathway
Autophagy|||Tyrosine Kinase/Adaptors|||Angiogenesis
Target
VEGFR|||Autophagy|||PDGFR|||c-Kit|||FLT

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2mg
Available: In stock
Listprice: €38.00
Price: €38.00
available

Delivery expected until 9/4/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close